false
OasisLMS
Login
Catalog
Expanding the Orthopedic DME Portfolio: Beyond Tra ...
Executive Summary
Executive Summary
Back to course
Pdf Summary
The session argues that orthopedic DME programs can create more patient value by moving beyond traditional bracing. Expansion can mean introducing a new offering or specialty, extending an established program to new locations, or improving consistent use of existing products. Growth should start with a meaningful clinical need—not revenue potential.<br /><br />Before investing, assess four factors: clinical value and accepted evidence, physician commitment, financial viability (including coverage and reimbursement), and operational readiness. Successful adoption requires a physician champion, team education, standardized protocols and ordering, and measurement of utilization before expanding.<br /><br />At scale, programs need clear workflows, trained and accountable staff, managed inventory, and confirmed reimbursement, authorization, coding, and documentation. Examples include extending cold therapy to additional surgery centers, adding osteoarthritis knee bracing through standardized selection and fitting, and piloting platelet-rich plasma alongside an existing system before replacing it.<br /><br />Discussion emphasized using case and procedure volumes to evaluate opportunities, prioritizing education, selecting vendors based on quality, cost, reimbursement, and support, and engaging clinicians directly. The central takeaway: expand where clinical value, physician commitment, payment, and operations align. If they do not yet align, deferring is a sound decision.
Keywords
orthopedic DME
patient value
bracing
clinical need
physician commitment
financial viability
operational readiness
reimbursement
standardized protocols
inventory management
×
Please select your language
1
English